Better Buy: Exact Sciences vs. Bio-Rad Laboratories

There are plenty of interesting healthcare stocks to choose from on the market right now. Whether they be small-cap biotechs, large-cap pharmaceutical giants, or anything in between, investors have no shortage of interesting investment possibilities to consider.

Two stocks that you might have heard of are Exact Sciences (NASDAQ: EXAS) and Bio-Rad Laboratories (NYSE: BIO). They are similarly sized with market caps above $10 billion. Exact is focused on developing early detection diagnostics to identify signs of colon and rectal cancer in patients. Bio-Rad also develops diagnostic equipment but has a much broader scope and isn't focused on one particular condition like Exact Sciences.

While both companies have their pros and cons, is there a clear winner between these two healthcare companies?

Continue reading

Source Fool.com